Notably, the hypoxia/glycolysis signature contains intestinal differentiation markers (e.g., TFF3, FABP1, KRT19; Figure 1c), indicating an association of distinct metabolic states with tumor cell differentiation and proliferation, as recently described for the normal intestinal crypt [23]. This evidence concerns the gene KRT19 and neoplasm.